Products
Building on the success of our first commercial products and leveraging the robust CollaRx® technology, Innocoll has identified a strategic portfolio of pipeline products which utilize our proprietary technologies.
We have purposefully selected product opportunities that address unmet medical needs of patients, providing benefit from the targeted delivery mechanism which our technologies afford. Our technologies have been scaled-up and commercialized in both the US and Europe. Our lead product, CollaRx® Gentamicin Surgical Implant, is on the market in Europe, and is currently in advanced stage clinical development for the US.